matched placebo
matched placebo is a pharmaceutical drug with 51 clinical trials. Currently 6 active trials ongoing. Historical success rate of 80.5%.
Success Metrics
Based on 33 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
18
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.7%
33 of 43 finished
23.3%
10 ended early
6
trials recruiting
51
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Glucokinase Activator in Monogenic Diabetes
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
VTP-1000 in Adults With Celiac Disease
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Clinical Trials (51)
Glucokinase Activator in Monogenic Diabetes
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
VTP-1000 in Adults With Celiac Disease
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Tranexamic Acid for Anaemia Trial
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
Study Investigating the Safety, Tolerability, and PK, PD, of CB-0406
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 51